The United States will pay pharmaceutical company Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment if the FDA authorizes it. Pfizer requested the FDA to authorize the pill for emergency use on Tuesday. “With more than 5 million deaths and countless lives impacted by this devastating disease globally, there is
More
Today: April 21, 2026